Identification of pVHL as a Novel Substrate for Aurora-A in Clear Cell Renal Cell Carcinoma (ccRCC)

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Martin, Benedicte ^a   Chesnel, Franck ^a   Delcros, Jean Guy ^b   Jouan, Florence ^a   Couturier, Anne ^a   Dugay, Frederic ^a   Le Goff, Xavier ^a   Patard, Jean Jacques ^c   Fergelot, Patricia ^d   Vigneau, Cecile ^a,e   Rioux Leclerq, Nathalie ^a,e   Arlot Bonnemains, Yannick ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b CENTRE LÉON BÉRARD   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d BICÊTRE HOSPITAL   (France)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; SERINE; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER CELL; CANCER GRADING; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE INTERACTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; NEPHRECTOMY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE; VHL GENE;

AURORA KINASE A; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MODELS, BIOLOGICAL; MUTATION; NEOPLASM GRADING; PHOSPHORYLATION; PROTEIN BINDING; TRANSCRIPTION, GENETIC; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 84879035470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067071     Document Type: Article

References (32)

1. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, et al. (1988) Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 332: 268-269. doi:10.1038/332268a0. PubMed: 2894613.
2. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, et al. (1994) Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 3: 1303-1308. doi:10.1093/hmg/3.8.1303. PubMed: 7987306.
3. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, et al. (1997) The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133. doi:10.1002/(SICI)1096-9896(199710)183:2. PubMed: 9390023.
4. Chen F, Kishida T, Duh FM, Renbaum P, Orcutt ML, et al. (1995) Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res 55: 4804-4807. PubMed: 7585510.
5. Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, et al. (1994) Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69: 230-234. doi:10.1038/bjc.1994.44. PubMed: 8297719.
6. Kaelin WG Jr., (2002) Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2: 673-682. doi:10.1038/nrc885. PubMed: 12209156.
7. Kim WY, Kaelin WG, (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22: 4991-5004. doi:10.1200/JCO.2004.05.061. PubMed: 15611513.
8. Pause A, Lee S, Lonergan KM, Klausner RD, (1998) The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci U S A 95: 993-998. doi:10.1073/pnas.95.3.993. PubMed: 9448273.
9. Seagroves T, Johnson RS, (2002) Two HIFs may be better than one. Cancer Cell 1: 211-213. doi:10.1016/S1535-6108(02)00048-X. PubMed: 12086854.
10. Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W, (2003) Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 5: 64-70. doi:10.1038/ncb899. PubMed: 12510195.
11. Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, et al. (2009) VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol 11: 994-1001. doi:10.1038/ncb1912. PubMed: 19620968.
12. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, et al. (1998) A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 17: 3052-3065. doi:10.1093/emboj/17.11.3052. PubMed: 9606188.
13. Arlot-Bonnemains Y, Klotzbucher A, Giet R, Uzbekov R, Bihan R, et al. (2001) Identification of a functional destruction box in the Xenopus laevis aurora-A kinase pEg2. FEBS Lett 508: 149-152. doi:10.1016/S0014-5793(01)03048-4. PubMed: 11707286.
14. Royce ME, Xia W, Sahin AA, Katayama H, Johnston DA, et al. (2004) STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis. Cancer 100: 12-19. doi:10.1002/cncr.11879. PubMed: 14692019.
15. Buschhorn HM, Klein RR, Chambers SM, Hardy MC, Green S, et al. (2005) Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate 64: 341-346. doi:10.1002/pros.20247. PubMed: 15754349.
16. Ulisse S, Baldini E, Toller M, Delcros JG, Guého A, et al. (2007) Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Endocr Relat Cancer 14: 827-837. doi:10.1677/ERC-07-0053. PubMed: 17914111.
17. Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, et al. (2006) Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. Int J Cancer 119: 275-282. doi:10.1002/ijc.21842. PubMed: 16477625.
18. Ampofo E, Kietzmann T, Zimmer A, Jakupovic M, Montenarh M, et al. (2010) Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. Int J Biochem Cell Biol 42: 1729-1735. doi:10.1016/j.biocel.2010.07.008. PubMed: 20637892.
19. Motzer RJ, Bander NH, Nanus DM, (1996) Renal-cell carcinoma. N Engl J Med 335: 865-875. doi:10.1056/NEJM199609193351207. PubMed: 8778606.
20. Ehara H, Yokoi S, Tamaki M, Nishino Y, Takahashi Y, et al. (2003) Expression of mitotic Aurora/Ipl1p-related kinases in renal cell carcinomas: an immunohistochemical study. Urol Res 31: 382-386. doi:10.1007/s00240-003-0354-x. PubMed: 13680024.
21. Kurahashi T, Miyake H, Hara I, Fujisawa M, (2007) Significance of Aurora-A expression in renal cell carcinoma. Urol Oncol 25: 128-133. doi:10.1016/j.urolonc.2006.06.001. PubMed: 17349527.
22. Patard JJ, Rioux-Leclercq N, Masson D, Zerrouki S, Jouan F, et al. (2009) Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma. Br J Cancer 101: 1417-1424. doi:10.1038/sj.bjc.6605298. PubMed: 19755989.
23. Patard JJ, (2009) Incidental renal tumours. Curr Opin Urol 19: 454-458. doi:10.1097/MOU.0b013e32832f0ccd. PubMed: 19571758.
24. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, et al. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275. doi:10.1038/20459. PubMed: 10353251.
25. Klotzbucher A, Pascreau G, Prigent C, Arlot-Bonnemains Y, (2002) A Method for Analyzing the Ubiquitination and Degradation of Aurora-A. Biol Proced Online 4: 62-69. doi:10.1251/bpo35. PubMed: 12734567.
26. Kimura M, [!(surname)!], Hattori T, Sumi N, Yoshioka T, Todokoro K, Okano Y, (1997) Cell cycle-dependent expression and spindle pole localization of a novel human protein kinase, Aik, related to Aurora of Drosophila and yeast Ipl1. J Biol Chem 272(21):: 13766-13771. doi:10.1074/jbc.272.21.13766. PubMed: 9153231.
27. Bodmer D, Eleveld M, Ligtenberg M, Weterman M, van der Meijden A, et al. (2002) Cytogenetic and molecular analysis of early stage renal cell carcinomas in a family with a translocation (2;3)(q35;q21). Cancer Genet Cytogenet 134: 6-12. doi:10.1016/S0165-4608(01)00585-4. PubMed: 11996788.
28. Hoque A, Carter J, Xia W, Hung MC, Sahin AA, et al. (2003) Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 12: 1518-1522.
29. Lei Y, Yan S, Ming-De L, [!(surname)!], Rui-Fa H, (2011) Prognostic significance of Aurora-A expression in human bladder cancer. Acta histochemica 113: 514-518.
30. Bufo P, Sanguedolce F, Tortorella S, Cormio L, Carrieri G, et al. (2010) Expression of mitotic kinases phospho-aurora A and aurora B correlates with clinical and pathological parameters in bladder neoplasms. Histol Histopathol 25: 1371-1377. PubMed: 20865660.
31. Thoenes W, Storkel S, Rumpelt HJ, (1986) Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Practice 181: 125-143. doi:10.1016/S0344-0338(86)80001-2.
32. Hergovich A, Lisztwan J, Thoma CR, Wirbelauer C, Barry RE, et al. (2006) Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. Mol Cell Biol 26: 5784-5796. doi:10.1128/MCB.00232-06. PubMed: 16847331.